443 related articles for article (PubMed ID: 30813440)
1. Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial.
Parker HM; Cohn JS; O'Connor HT; Garg ML; Caterson ID; George J; Johnson NA
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813440
[TBL] [Abstract][Full Text] [Related]
2. Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial.
Barroso LN; Salarini J; Leite NC; Villela-Nogueira CA; Dávalos A; Carmo MDGT; Ferreira Peres WA
Clin Nutr ESPEN; 2023 Oct; 57():117-125. PubMed ID: 37739645
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
[TBL] [Abstract][Full Text] [Related]
4. Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial.
Cansanção K; Citelli M; Carvalho Leite N; López de Las Hazas MC; Dávalos A; Tavares do Carmo MDG; Peres WAF
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33147705
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
6. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Calder PC; Byrne CD;
Contemp Clin Trials; 2014 Mar; 37(2):301-11. PubMed ID: 24556343
[TBL] [Abstract][Full Text] [Related]
7. Effects of fish oil-derived n-3 polyunsaturated fatty acid on body composition, muscle strength and physical performance in older people: a secondary analysis of a randomised, double-blind, placebo-controlled trial.
Xu D; Lu Y; Yang X; Pan D; Wang Y; Yin S; Wang S; Sun G
Age Ageing; 2022 Dec; 51(12):. PubMed ID: 36571774
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
[TBL] [Abstract][Full Text] [Related]
9. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
Grenon SM; Owens CD; Nosova EV; Hughes-Fulford M; Alley HF; Chong K; Perez S; Yen PK; Boscardin J; Hellmann J; Spite M; Conte MS
J Am Heart Assoc; 2015 Aug; 4(8):e002034. PubMed ID: 26296857
[TBL] [Abstract][Full Text] [Related]
10. Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects.
Gammelmark A; Madsen T; Varming K; Lundbye-Christensen S; Schmidt EB
Nutr Res; 2012 Jan; 32(1):15-23. PubMed ID: 22260859
[TBL] [Abstract][Full Text] [Related]
11. Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content.
Espinosa A; Valenzuela R; González-Mañán D; D'Espessailles A; Guillermo Gormaz J; Barrera C; Tapia G
Arch Latinoam Nutr; 2013 Mar; 63(1):29-36. PubMed ID: 24167955
[TBL] [Abstract][Full Text] [Related]
12. Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial.
Jones KD; Ali R; Khasira MA; Odera D; West AL; Koster G; Akomo P; Talbert AW; Goss VM; Ngari M; Thitiri J; Ndoro S; Knight MA; Omollo K; Ndungu A; Mulongo MM; Bahwere P; Fegan G; Warner JO; Postle AD; Collins S; Calder PC; Berkley JA
BMC Med; 2015 Apr; 13():93. PubMed ID: 25902844
[TBL] [Abstract][Full Text] [Related]
13. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
14. The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition.
Dunstan JA; Roper J; Mitoulas L; Hartmann PE; Simmer K; Prescott SL
Clin Exp Allergy; 2004 Aug; 34(8):1237-42. PubMed ID: 15298564
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials.
Chen LH; Wang YF; Xu QH; Chen SS
Clin Nutr; 2018 Apr; 37(2):516-521. PubMed ID: 28040302
[TBL] [Abstract][Full Text] [Related]
16. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
Oscarsson J; Önnerhag K; Risérus U; Sundén M; Johansson L; Jansson PA; Moris L; Nilsson PM; Eriksson JW; Lind L
J Clin Lipidol; 2018; 12(6):1390-1403.e4. PubMed ID: 30197273
[TBL] [Abstract][Full Text] [Related]
17. Acute fish oil and soy isoflavone supplementation increase postprandial serum (n-3) polyunsaturated fatty acids and isoflavones but do not affect triacylglycerols or biomarkers of oxidative stress in overweight and obese hypertriglyceridemic men.
Hanwell HE; Kay CD; Lampe JW; Holub BJ; Duncan AM
J Nutr; 2009 Jun; 139(6):1128-34. PubMed ID: 19339704
[TBL] [Abstract][Full Text] [Related]
18. Long-chain polyunsaturated fatty acid supplementation had no effect on body weight but reduced energy intake in overweight and obese women.
Harden CJ; Dible VA; Russell JM; Garaiova I; Plummer SF; Barker ME; Corfe BM
Nutr Res; 2014 Jan; 34(1):17-24. PubMed ID: 24418242
[TBL] [Abstract][Full Text] [Related]
19. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
Kelley NS
Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
